(2023) 52:e12734
Sources and scientific studies Ameli.fr Anti-diabetic medications: Support for prescribing ANSM GLP-1 analogues indicated in the treatment of obesity: ANSM changes their prescribing and dispensing conditions, 2025 Decrees of May 23, 2026 amending the list of pharmaceutical specialties reimbursable to social security beneficiaries (Wegovy, Mounjaro), Official Journal of May 28, 2026 HAS Opinion of the Transparency Commission, Wegovy (2024) and Mounjaro (2025) John P H Wilding, Rachel L Batterham, Salvatore Calanna, Melanie Davies, Luc F Van Gaal, Ildiko Lingvay, Barbara M McGowan, Julio Rosenstock, Marie T D Tran, Thomas A Wadden, Sean Wharton, Koutaro Yokote, Niels Zeuthen, Robert F Kushner, STEP 1 Study Group, Once-Weekly Semaglutide in Adults with Overweight or Obesity, N Engl J Med, 2021
Immune Peptides: Thymosin Alpha-1, LL-37, and KPV Thymosin Alpha-1 has the deepest clinical track record of any peptide on this list
TB-4 plays a crucial role in the protection, repair, regeneration, and remodeling of injured or damaged tissues, making it a focal point in research related to tissue healing and regeneration